Pfizer Is Working on an Anti-COVID Pill but Only for Those Who Don’t Actually Need It
That's one way to ensure that it "works"
Are you, like most people, a low-risk healthy individual who is absolutely not in danger of anything from COVID? If so, you are in luck because Pfizer has something for you:
Success against #COVID19 will likely require both vaccines & treatments. We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate—specifically designed to combat SARS-CoV-2—in non-hospitalized, low-risk adults:
To go with your vaccine that you don’t need Pfizer now also has a pill that you also don’t need!
It’s a pill to “treat” COVID specifically in… people who do not need treatment.
Color me skeptical but it stands to reason that if vaccines worked you wouldn’t need a treatment pill. And if the treatment worked it would be offered to those who are actually *threatened*.
Back during the manufactured 2009 Swine Flu hysteria, there was the Tamiflu pill scam that fell apart when it was later found to be backed by bogus data. After Anthony Fauci had the US stockpile $1.5 billion worth of it, the pill by Roche AG was by 2014 implicated in potentially fatal heart problems and was understood to be useless against the flu anyway — it perhaps cut the duration of mild symptoms in the not-at-risk by 12 hours but did nothing to cut hospital admissions or complications in the at-risk groups.
It seems Pfizer wants to “get around” the “uselessness problem” by targeting specifically the healthy. — It’s brilliant really, why didn’t Roche think of that? Instead, Roche went the much cruder route of hiding its clinical data from the public. Pfizer is going to proclaim its pill is snake oil from day one, and thanks to COVID lemmings is going to reap a fortune anyway. You can’t even really call it a “scam” — a scam would have to involve deception but Pfizer is forthright.
Success against #COVID19 will likely require both vaccines & treatments. We’re pleased to share we’ve started a Phase 2/3 study of our oral antiviral candidate—specifically designed to combat SARS-CoV-2—in non-hospitalized, low-risk adults: https://t.co/su5VtfbWPX
— AlbertBourla (@AlbertBourla) September 1, 2021
Twice a day Covid pill by Pfizer pic.twitter.com/S5guXlcm7z
— Osler (@osler78) September 1, 2021